Menu

Filters

  • Result Found In

AVANOS Pain Management and Recovery

AVANOS Pain Management and Recovery

AVANOS Pain Management and Recovery - Henry Schein Medical

Supported by published clinical data

AVANOS Pain Management and Recovery offers two hyaluronic acid (HA) injection products, GenVisc*850 and TriVisc*, which are both indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.†

GenVisc850 5-injection regimen - Henry Schein Medical

GenVisc850 5-injection regimen

Proven:

  • GenVisc850 has been published in over 30 clinical studies†
  • Approved in 64 countries with over 45 million syringes distributed worldwide†

Safe:

  • Demonstrated safe for repeat injection cycles†
  • Safe as saline placebo†
  • Free of avian proteins†

Effective:

  • Demonstrated improvement in pain relief up to 30 weeks post first injection cycle†
  • Demonstrated improvement of total WOMAC index at 30 weeks: Pain, stiffness, and functional capacity¹
TriVisc 3-injection regimen - Henry Schein Medical

TriVisc 3-injection regimen

Trusted:

  • 35 million doses administered worldwide†
  • Exhibited improvement in WOMAC, and VAS scores compared to the baseline†

Pure:

  • Highly purified HA produced by bacterial biofermentation technology†
  • Removes the risk of avian allergies and sensitivities†
  • Safe for repeat injection cycles†

HARMOKNEE Support Services

HA Support for Practices and Patients.

HARMOKNEE Reimbursement Solutions makes it simple to access HA so you can deliver the best patient experience possible.

See www.orthogenrx.com for more information.


Claim data on file at Avanos ¹ Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la Serna AR, Naranjo A, Gimeno M, Herrero-Beaumont G; AMELIA study group. A 40-month multicenter, randomized placebo-controlled study to assess the efficacy and carry- over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70: 1957-62.

*Registered Trademark or Trademark of Avanos Medical, Inc. or its affiliates. ©2023 Avanos Medical, Inc., All Rights Reserved. COPY-07698